Cargando…

Can Polymetastatic Disease Be ARRESTed Using SABR? A Dosimetric Feasibility Study to Inform Development of a Phase 1 Trial

PURPOSE: Phase 2 randomized trials suggest that stereotactic ablative radiation therapy improves progression-free and overall survival in patients with oligometastatic cancer, with phase 3 trials currently testing stereotactic ablative radiation therapy in up to 10 metastases. Whether stereotactic r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corkum, Mark T., Fakir, Hatim, Palma, David A., Nguyen, Timothy, Bauman, Glenn S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267486/ https://www.ncbi.nlm.nih.gov/pubmed/34278053 http://dx.doi.org/10.1016/j.adro.2021.100734

Ejemplares similares

Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy
por: Bauman, Glenn S., et al.
Publicado: (2021)

Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts
por: Goodman, Christopher D., et al.
Publicado: (2019)

Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center
por: Arifin, Andrew J., et al.
Publicado: (2023)

A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study
por: Nicosia, Luca, et al.
Publicado: (2022)

A Novel Salvage Option for Local Failure in Prostate Cancer, Reirradiation Using External Beam or Stereotactic Radiation Therapy: Systematic Review and Meta-Analysis
por: Corkum, Mark T., et al.
Publicado: (2020)

Clinical Factors That Affect Fiducial Tracking in Robotic SABR for Lung Tumors
por: Huynh, Duy, et al.
Publicado: (2023)

Dosimetric effects of immobilization devices on SABR for lung cancer using VMAT technique
por: Park, Jong In, et al.
Publicado: (2015)

Optimization of the dosimetric leaf gap for use in planning VMAT treatments of spine SABR cases
por: Middlebrook, Nigel D, et al.
Publicado: (2017)

Dosimetric Planning Comparison for Left-Sided Breast Cancer Radiotherapy: The Clinical Feasibility of Four-Dimensional-Computed Tomography-Based Treatment Planning Optimization
por: Chau, Oi-Wai, et al.
Publicado: (2022)

Expanding the Utilization of Rectal Spacer Hydrogel for Larger Prostate Glands (>80 cc): Feasibility and Dosimetric Outcomes
por: Fagundes, Marcio, et al.
Publicado: (2021)

Endobronchially Implanted Real-Time Electromagnetic Transponder Beacon–Guided, Respiratory-Gated SABR for Moving Lung Tumors: A Prospective Phase 1/2 Cohort Study
por: Cheng, Jui Chih, et al.
Publicado: (2023)

Interval From Simulation Imaging to Treatment Delivery in SABR of Lung Lesions: How Long is Too Long for the Lung?
por: Colin, Gilles, et al.
Publicado: (2022)

Efficacy and Safety of Stereotactic Body Radiation Therapy for Pediatric Malignancies: The LITE-SABR Systematic Review and Meta-Analysis
por: Singh, Raj, et al.
Publicado: (2023)

Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs
por: Lussier, Yves A., et al.
Publicado: (2012)

Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer
por: Shirasawa, Masayuki, et al.
Publicado: (2019)

Correction: Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs
por: Lussier, Yves A., et al.
Publicado: (2013)

Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression
por: Sun, Zhiwei, et al.
Publicado: (2018)

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
por: Olson, Robert, et al.
Publicado: (2018)

T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung Cancer
por: Hsu, Eric J., et al.
Publicado: (2022)

A robust VMAT delivery solution for single‐fraction lung SABR utilizing FFF beams minimizing dosimetric compromise
por: Burton, Alex, et al.
Publicado: (2020)

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
por: Palma, David A., et al.
Publicado: (2020)

Quantification of hyperpolarisation efficiency in SABRE and SABRE-Relay enhanced NMR spectroscopy
por: Richardson, Peter M., et al.
Publicado: (2018)

Exploring the microRNA profiles as potential diagnostic probes for oligo- and polymetastatic prognosis of lung metastasis(es) patients
por: Wang, Zhichao, et al.
Publicado: (2018)

Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer
por: Xu, Li-Ming, et al.
Publicado: (2017)

Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies
por: Petrelli, Fausto, et al.
Publicado: (2022)

Dosimetric Comparison of Proton Versus Photon Radiosurgery for Treatment of Pituitary Adenoma
por: Sud, Shivani, et al.
Publicado: (2021)

A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)
por: Hasan, Hamza, et al.
Publicado: (2020)

Dosimetric advantages of intensity modulated radiation therapy in locally advanced lung cancer
por: Boyle, John, et al.
Publicado: (2017)

A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma
por: Correa, Rohann J. M., et al.
Publicado: (2018)

SABRE : sistema de reservaciones para agencias de viajes
por: Mata Hernández, Elizabeth
Publicado: (1999)

Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus
por: Xu, Cai, et al.
Publicado: (2017)

SABRE: a system for the assessment of body radioactivity ; 2, main features of SABRE 3
por: Venn, J B
Publicado: (1978)

Daily Ultrasound Imaging for Patients Undergoing Postprostatectomy Radiation Therapy Predicts and Ensures Dosimetric Endpoints
por: Reilly, Michael, et al.
Publicado: (2020)

Dosimetric Uncertainties in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy
por: Zhou, Jun, et al.
Publicado: (2021)

Dosimetric evaluation of an intraoperative radiotherapy system: a measurement-based and Monte-Carlo modelling investigation
por: Chin, Marsha, et al.
Publicado: (2023)

Sistema de reservaciones SABRE /
por: Ramírez Juárez, Magdalena
Publicado: (2000)

To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer
por: Kim, Joshua, et al.
Publicado: (2016)

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
por: Palma, David A., et al.
Publicado: (2019)

Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI
por: Liu, Wei, et al.
Publicado: (2021)

Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy
por: Owen, Dawn, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_51jnp02e1d5vbp8dusi31q6hgp